Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Toxoplasma gondii | aspartyl protease ASP1 | 0.0047 | 0.1266 | 0.5 |
Brugia malayi | celfurPC protein | 0.0117 | 0.749 | 0.6937 |
Toxoplasma gondii | aspartyl proteinase (eimepsin), putative | 0.0047 | 0.1266 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0053 | 0.1803 | 0.1803 |
Trichomonas vaginalis | Clan AA, family A1, cathepsin D-like aspartic peptidase | 0.0047 | 0.1266 | 0.2444 |
Echinococcus multilocularis | calpain A | 0.0056 | 0.202 | 0.2611 |
Loa Loa (eye worm) | aspartic protease BmAsp-2 | 0.0047 | 0.1266 | 0.1266 |
Plasmodium falciparum | plasmepsin II | 0.0047 | 0.1266 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0039 | 0.0542 | 0.0542 |
Schistosoma mansoni | subfamily A1A unassigned peptidase (A01 family) | 0.0047 | 0.1266 | 0.1189 |
Echinococcus granulosus | family C2 unassigned peptidase C02 family | 0.0056 | 0.202 | 0.1949 |
Echinococcus granulosus | neuroendocrine convertase 2 | 0.0091 | 0.5178 | 0.5135 |
Schistosoma mansoni | furin-1 (S08 family) | 0.0063 | 0.2667 | 0.2603 |
Loa Loa (eye worm) | hypothetical protein | 0.0057 | 0.2113 | 0.2113 |
Loa Loa (eye worm) | hypothetical protein | 0.0047 | 0.1261 | 0.1261 |
Brugia malayi | proprotein convertase 2 | 0.0091 | 0.5178 | 0.4117 |
Echinococcus granulosus | calpain A | 0.0056 | 0.202 | 0.1949 |
Loa Loa (eye worm) | calpain family protein 1 | 0.0039 | 0.0542 | 0.0542 |
Echinococcus multilocularis | calpain family protein 1, d | 0.0039 | 0.0542 | 0.0614 |
Echinococcus multilocularis | proprotein convertase subtilisin:kexin type 5 | 0.0088 | 0.491 | 0.6515 |
Giardia lamblia | High cysteine membrane protein Group 2 | 0.0054 | 0.1845 | 0.5 |
Echinococcus multilocularis | cathepsin d (lysosomal aspartyl protease) | 0.0047 | 0.1266 | 0.1592 |
Plasmodium vivax | plasmepsin IV, putative | 0.0047 | 0.1266 | 0.5 |
Schistosoma mansoni | family C2 unassigned peptidase (C02 family) | 0.0053 | 0.1803 | 0.1731 |
Echinococcus multilocularis | 0.0117 | 0.749 | 1 | |
Loa Loa (eye worm) | calpain family protein 1 | 0.0053 | 0.1803 | 0.1803 |
Plasmodium vivax | aspartyl proteinase, putative | 0.0047 | 0.1266 | 0.5 |
Schistosoma mansoni | family C2 unassigned peptidase (C02 family) | 0.0056 | 0.202 | 0.1949 |
Echinococcus granulosus | cathepsin d lysosomal aspartyl protease | 0.0047 | 0.1266 | 0.1189 |
Trichomonas vaginalis | Clan SB, family S8, subtilisin-like serine peptidase | 0.0088 | 0.491 | 1 |
Echinococcus granulosus | proprotein convertase subtilisin:kexin type 5 | 0.0088 | 0.491 | 0.4865 |
Schistosoma mansoni | family C2 unassigned peptidase (C02 family) | 0.0056 | 0.202 | 0.1949 |
Plasmodium falciparum | plasmepsin I | 0.0047 | 0.1266 | 0.5 |
Loa Loa (eye worm) | endoprotease bli-4 | 0.0145 | 1 | 1 |
Onchocerca volvulus | 0.0033 | 0 | 0.5 | |
Loa Loa (eye worm) | hypothetical protein | 0.0047 | 0.1266 | 0.1266 |
Schistosoma mansoni | subfamily S8B unassigned peptidase (S08 family) | 0.0145 | 1 | 1 |
Brugia malayi | neuroendocrine convertase 1 precursor | 0.0091 | 0.5178 | 0.4117 |
Plasmodium falciparum | plasmepsin VI | 0.0047 | 0.1266 | 0.5 |
Echinococcus multilocularis | neuroendocrine convertase 2 | 0.0091 | 0.5178 | 0.6877 |
Loa Loa (eye worm) | proprotein convertase 2 | 0.0034 | 0.0088 | 0.0088 |
Loa Loa (eye worm) | hypothetical protein | 0.0145 | 1 | 1 |
Schistosoma mansoni | cathepsin D (A01 family) | 0.0139 | 0.9534 | 0.9529 |
Echinococcus multilocularis | family C2 unassigned peptidase (C02 family) | 0.0056 | 0.202 | 0.2611 |
Plasmodium falciparum | plasmepsin IV | 0.0047 | 0.1266 | 0.5 |
Echinococcus granulosus | furin | 0.0145 | 1 | 1 |
Trichomonas vaginalis | Clan SB, family S8, subtilisin-like serine peptidase | 0.0088 | 0.491 | 1 |
Schistosoma mansoni | cathepsin D (A01 family) | 0.0139 | 0.9534 | 0.9529 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.